UNLIMITED TURBO LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 20:50:29 27/06/2024 BST | ||
| 2.35 EUR | -4.08% |
|
| Current month | -9.59% | ||
| 1 month | -12.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 2.45 | 0.00% |
| 26/06/24 | 2.45 | -0.81% |
| 25/06/24 | 2.47 | -6.08% |
| 24/06/24 | 2.63 | +4.37% |
| 21/06/24 | 2.52 | +3.28% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0ZFN |
| ISIN | DE000PZ0ZFN0 |
| Date issued | 03/11/2023 |
| Strike | 115.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.18 € |
|---|---|
| Lowest since issue | 1.28 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.03%
- Stock Market
- Certificates
- Certificat
